Skip to main content
OpenTrials
Completed

NCT Number: NCT01339520

Diabetes Scorecard Educational Intervention Study

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical Faculty Associates, George Washington University

Washington D.C., District of Columbia, 20037, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Uncontrolled Type II diabetes (HbA1c ≥ 8%)

Exclusion criteria

  • Type I Diabetes
  • HbA1c < 8%
  • Inability to understand the diabetes scorecard due to condition (i.e. dementia, mental retardation, etc) or language barrier
  • Pregnancy
  • Planning to move within the next year

Treatment and study plan

Scorecard

Behavioral

Points were assigned for blood pressure, HbA1c level, LDL-cholesterol level, aspirin use and exercise level.

Control

Behavioral

Standard of care for diabetes subjects

Primary outcomes

  1. Change in total score

    Time frame: 9 months

    The total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.

Secondary outcomes

  1. LDL-cholesterol

    Time frame: 9 months

  2. HbA1c

    Time frame: 9 months

    Measure of glycemic control

Sponsors and collaborators

Lead sponsor

George Washington University

Other

Registry information

Official study title

Use of a Card to Improve Risk Factor Control in Patients With Type II Diabetes

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Apr 20, 2011
Registry last updated
Aug 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.